Carboplatin / Cisplatin

DRUG2 trials

Sponsors

Suzhou Suncadia Biopharmaceuticals Co., Ltd., Second Affiliated Hospital, Zhejiang University, School of Medicine

Conditions

Extensive Disease Small Cell Lung CancerExtensive Stage Lung Small Cell CancerExtensive-Stage Small-Cell Lung CancerExtensive-stage Small Cell Lung Cancer (ES-SCLC)Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Phase 1

A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma Cancer

RecruitingNCT07059221

Suzhou Suncadia Biopharmaceuticals Co., Ltd.Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Start: 2025-07-11End: 2029-03-01Target: 210Updated: 2026-07-20

Phase 2

Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

RecruitingNCT07061535

Second Affiliated Hospital, Zhejiang University, School of MedicineExtensive-stage Small Cell Lung Cancer (ES-SCLC), Extensive Stage Lung Small Cell Cancer, Extensive-Stage Small-Cell Lung Cancer +1

Start: 2025-07-30End: 2027-08-01Target: 40Updated: 2026-09-15